Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 25;13(1):114.
doi: 10.1186/s13256-019-2024-9.

Critical limb ischemia in a patient with systemic lupus erythematosus: a case report

Affiliations
Review

Critical limb ischemia in a patient with systemic lupus erythematosus: a case report

Vito Damay et al. J Med Case Rep. .

Abstract

Background: Peripheral vascular disease is the rarest vascular complication in systemic lupus erythematosus. Some theories propose that immune complexes may promote inflammation in the vessel, and disrupt it in a manner that may cause ischemia.

Case presentation: A 14-year-old Asian girl presented with intermittent claudication as the chief complaint followed by discoloration of her left big toe for 2 weeks prior to admission. Her medical history showed that 1 month prior to admission she had photosensitivity, rash, and arthralgia, with positive antinuclear antibody test, positive anti-double-stranded DNA test, positive anti-ribosomal protein P, and complement C4 (7.4 mg/dL); she was diagnosed as having systemic lupus erythematosus and started therapy. A local examination of her left toe showed black discoloration, low pulsation, localized tenderness, and decreased sensation. Laboratory results showed C-reactive protein of 1.16 mg/dL and D-dimer of 2.28 uG/mL. A computed tomography angiogram showed near total occlusion of her popliteal artery; critical limb ischemia was confirmed. Peripheral arteriography was performed with invasive strategy. After the procedure, the flow was improved to distal, but there was inflammation in the vessel, so we decided to stop the procedure because of the risk of dissection. Our patient was given atorvastatin and warfarin, and we maximized her systemic lupus erythematosus therapy with prednisone. There were two follow-ups. The first follow-up was 1 week after the procedure. Our patient attended her first follow-up at our out-patient department with no symptoms and improvement in her toe's discoloration; warfarin was stopped, and clopidogrel and cilostazol were added for thrombus prevention therapy, she was then scheduled for debridement. The second follow-up was done 2 months after the first follow-up and discoloration was improved. The third follow-up, 5 months after the second follow-up, showed improvement.

Conclusion: Critical limb ischemia is a rare complication of systemic lupus erythematosus that requires immediate treatment. Due to our limited resources, we improvised a strategy to achieve the best possible outcome in our patient by using a combination of invasive treatment and medication.

Keywords: Critical limb ischemia; Immune complex; Peripheral angioplasty; Systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent was obtained from the patient’s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
a Black discoloration, low pulsation, positive localized tenderness, and decreased sensation. b Both feet are shown for comparison
Fig. 2
Fig. 2
Patient’s computed tomography-angiography. Patient’s computed tomography-angiography showing near total occlusion of the popliteal artery
Fig. 3
Fig. 3
a Patient’s digital subtraction angiography and angiography pre-intervention. b Soft wire through the lesion
Fig. 4
Fig. 4
a Multiple plain old balloon angioplasty dilatations. b Flow after multiple plain old balloon angioplasty dilatation procedures
Fig. 5
Fig. 5
Patient’s left big toe on first follow-up. The first follow-up was 1 week after the procedure. The follow-up took place at our out-patient department; our patient’s left big toe showed improvement in discoloration and no symptoms of claudication
Fig. 6
Fig. 6
Patient’s left big toe on second follow-up. The second follow-up was 2 months after the first follow-up; the improvement in discoloration was greater than the improvement on the first follow-up
Fig. 7
Fig. 7
Timeline of the disease. CLI critical limb ischemia, CT computed tomography, POBA plain old balloon angioplasty, PTA percutaneous transluminal angioplasty, SLE systemic lupus erythematosus, T0 1 month prior to admission, T1 on admission, T2 on follow-up

References

    1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277. doi: 10.1002/art.1780251101. - DOI - PubMed
    1. Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) Lancet. 2005;366:1773–1783. doi: 10.1016/S0140-6736(05)67702-1. - DOI - PubMed
    1. Chehab G, Fischer-Betz R, Schneider M. Changes in mortality and morbidity in systemic lupus erythematosus. Z Rheumatol. 2011;70(6):480–485. doi: 10.1007/s00393-011-0758-x. - DOI - PubMed
    1. Symmons DPM, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7(7):399–408. doi: 10.1038/nrrheum.2011.75. - DOI - PubMed
    1. Bhatt SP, Handa R, Gulati GS, Sharma S, Pandey RM, Aggarwal P, Ramakrishnan L, Shankar S. Peripheral vascular disease in systemic lupus erythematosus. Lupus. 2007;16(9):720–723. doi: 10.1177/0961203307081123. - DOI - PubMed

MeSH terms